The trademark BIPROSTINA was filed by SENJU PHARMACEUTICAL CO., LTD., a corporation established under the laws of Japan (the "Applicant"). The application was published for oppositions on September 7, 2023, and received one opposition filed on December 5, 2023 by BIOFARMA on Likelihood of confusion. the opponent was represented by CABINET GERMAIN & MAUREAU and proceedings were handled in French, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 5, 2023
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Change of name and address of the trademark registration was recorded on November 2, 2023.